vs

Side-by-side financial comparison of BayCom Corp (BCML) and Cryoport, Inc. (CYRX). Click either name above to swap in a different company.

Cryoport, Inc. is the larger business by last-quarter revenue ($45.5M vs $25.9M, roughly 1.8× BayCom Corp). BayCom Corp runs the higher net margin — 26.5% vs -17.5%, a 44.0% gap on every dollar of revenue. On growth, Cryoport, Inc. posted the faster year-over-year revenue change (9.6% vs 9.4%). BayCom Corp produced more free cash flow last quarter ($30.1M vs $-4.5M). Over the past eight quarters, Cryoport, Inc.'s revenue compounded faster (10.4% CAGR vs 2.9%).

BayCom Corp is a U.S.-headquartered bank holding company operating through its wholly owned subsidiary Bay Commercial Bank. It primarily serves small and medium-sized enterprises and retail customers across Northern California, offering commercial lending, deposit products, personal banking services, and localized wealth management solutions.

Cryoport, Inc. is a global provider of specialized temperature-controlled logistics and supply chain solutions focused on the life sciences, biopharmaceutical, and cell and gene therapy sectors. It partners with research institutions, biotech firms, and pharmaceutical manufacturers globally to support the safe transport of sensitive biological materials including clinical trial samples and advanced therapy products.

BCML vs CYRX — Head-to-Head

Bigger by revenue
CYRX
CYRX
1.8× larger
CYRX
$45.5M
$25.9M
BCML
Growing faster (revenue YoY)
CYRX
CYRX
+0.2% gap
CYRX
9.6%
9.4%
BCML
Higher net margin
BCML
BCML
44.0% more per $
BCML
26.5%
-17.5%
CYRX
More free cash flow
BCML
BCML
$34.6M more FCF
BCML
$30.1M
$-4.5M
CYRX
Faster 2-yr revenue CAGR
CYRX
CYRX
Annualised
CYRX
10.4%
2.9%
BCML

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BCML
BCML
CYRX
CYRX
Revenue
$25.9M
$45.5M
Net Profit
$6.9M
$-8.0M
Gross Margin
47.8%
Operating Margin
36.6%
-17.0%
Net Margin
26.5%
-17.5%
Revenue YoY
9.4%
9.6%
Net Profit YoY
12.1%
57.4%
EPS (diluted)
$0.63
$-0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCML
BCML
CYRX
CYRX
Q4 25
$25.9M
$45.5M
Q3 25
$25.7M
$44.2M
Q2 25
$24.7M
$45.5M
Q1 25
$24.3M
$41.0M
Q4 24
$23.7M
$41.5M
Q3 24
$25.6M
$38.3M
Q2 24
$23.8M
$39.7M
Q1 24
$24.5M
$37.3M
Net Profit
BCML
BCML
CYRX
CYRX
Q4 25
$6.9M
$-8.0M
Q3 25
$5.0M
$-6.9M
Q2 25
$6.4M
$105.2M
Q1 25
$5.7M
$-12.0M
Q4 24
$6.1M
$-18.7M
Q3 24
$6.0M
$805.0K
Q2 24
$5.6M
$-78.0M
Q1 24
$5.9M
$-18.9M
Gross Margin
BCML
BCML
CYRX
CYRX
Q4 25
47.8%
Q3 25
48.2%
Q2 25
47.0%
Q1 25
45.4%
Q4 24
47.0%
Q3 24
45.5%
Q2 24
44.5%
Q1 24
40.4%
Operating Margin
BCML
BCML
CYRX
CYRX
Q4 25
36.6%
-17.0%
Q3 25
26.3%
-22.5%
Q2 25
35.3%
-21.2%
Q1 25
31.6%
-23.1%
Q4 24
34.2%
-30.7%
Q3 24
32.4%
-34.9%
Q2 24
31.9%
-196.5%
Q1 24
33.3%
-46.9%
Net Margin
BCML
BCML
CYRX
CYRX
Q4 25
26.5%
-17.5%
Q3 25
19.5%
-15.7%
Q2 25
25.8%
231.4%
Q1 25
23.4%
-29.2%
Q4 24
25.9%
-45.1%
Q3 24
23.5%
2.1%
Q2 24
23.6%
-196.4%
Q1 24
24.0%
-50.7%
EPS (diluted)
BCML
BCML
CYRX
CYRX
Q4 25
$0.63
$-0.19
Q3 25
$0.46
$-0.18
Q2 25
$0.58
$2.05
Q1 25
$0.51
$-0.28
Q4 24
$0.55
$-0.42
Q3 24
$0.54
$-0.02
Q2 24
$0.50
$-1.62
Q1 24
$0.51
$-0.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCML
BCML
CYRX
CYRX
Cash + ST InvestmentsLiquidity on hand
$411.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$338.6M
$502.6M
Total Assets
$2.6B
$765.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCML
BCML
CYRX
CYRX
Q4 25
$411.2M
Q3 25
$421.3M
Q2 25
$426.0M
Q1 25
$244.0M
Q4 24
$250.6M
Q3 24
$259.4M
Q2 24
$414.9M
Q1 24
$438.2M
Stockholders' Equity
BCML
BCML
CYRX
CYRX
Q4 25
$338.6M
$502.6M
Q3 25
$334.3M
$513.3M
Q2 25
$330.6M
$519.1M
Q1 25
$329.3M
$398.8M
Q4 24
$324.4M
$401.9M
Q3 24
$321.7M
$418.6M
Q2 24
$315.3M
$400.1M
Q1 24
$314.2M
$472.2M
Total Assets
BCML
BCML
CYRX
CYRX
Q4 25
$2.6B
$765.0M
Q3 25
$2.6B
$774.3M
Q2 25
$2.6B
$773.9M
Q1 25
$2.6B
$699.8M
Q4 24
$2.7B
$703.5M
Q3 24
$2.6B
$701.8M
Q2 24
$2.6B
$852.3M
Q1 24
$2.6B
$942.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCML
BCML
CYRX
CYRX
Operating Cash FlowLast quarter
$31.8M
$919.0K
Free Cash FlowOCF − Capex
$30.1M
$-4.5M
FCF MarginFCF / Revenue
116.2%
-10.0%
Capex IntensityCapex / Revenue
6.7%
12.0%
Cash ConversionOCF / Net Profit
4.64×
TTM Free Cash FlowTrailing 4 quarters
$51.1M
$-25.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCML
BCML
CYRX
CYRX
Q4 25
$31.8M
$919.0K
Q3 25
$7.3M
$2.2M
Q2 25
$6.4M
$-7.3M
Q1 25
$9.3M
$-4.3M
Q4 24
$30.4M
$-5.5M
Q3 24
$9.6M
$447.0K
Q2 24
$7.7M
$-8.0M
Q1 24
$5.1M
$-3.3M
Free Cash Flow
BCML
BCML
CYRX
CYRX
Q4 25
$30.1M
$-4.5M
Q3 25
$6.2M
$-1.3M
Q2 25
$5.6M
$-11.7M
Q1 25
$9.1M
$-7.5M
Q4 24
$28.7M
$-10.7M
Q3 24
$9.4M
$-3.8M
Q2 24
$7.4M
$-11.8M
Q1 24
$3.9M
$-7.3M
FCF Margin
BCML
BCML
CYRX
CYRX
Q4 25
116.2%
-10.0%
Q3 25
24.3%
-2.9%
Q2 25
22.8%
-25.7%
Q1 25
37.6%
-18.3%
Q4 24
121.1%
-25.8%
Q3 24
36.6%
-9.9%
Q2 24
31.2%
-29.8%
Q1 24
16.1%
-19.5%
Capex Intensity
BCML
BCML
CYRX
CYRX
Q4 25
6.7%
12.0%
Q3 25
4.3%
7.8%
Q2 25
3.0%
9.6%
Q1 25
0.6%
7.7%
Q4 24
7.2%
12.6%
Q3 24
1.0%
11.1%
Q2 24
1.0%
9.5%
Q1 24
4.7%
10.7%
Cash Conversion
BCML
BCML
CYRX
CYRX
Q4 25
4.64×
Q3 25
1.47×
Q2 25
1.00×
-0.07×
Q1 25
1.63×
Q4 24
4.96×
Q3 24
1.60×
0.56×
Q2 24
1.37×
Q1 24
0.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons